Jazz Pharmaceuticals PLC at Jefferies Healthcare Conference (Virtual) Transcript
Good afternoon, everyone, and welcome to day 2 of the Jefferies Healthcare Conference. We're delighted to have with us the management team of Jazz, and it also looks like the CEO of GW Pharma, which I did not know you were going to be joining Justin, so thank you.
With us is Renee Gala, Chief Financial Officer; Robert Iannone, Head of R&D., I believe, that's your title Rob; and Kim Sablich, and I don't know your title, I apologize. And so we will start off with Renee, who will kick off the session with a couple of minutes of comments before we get into Q&A. Thank you.
Great. Thank you, David, and thank you for inviting us to participate. As we get started, I'll just remind you, we'll be making forward-looking statements today, so I'll point you to the risk factors outlined in our SEC statements. So it is a very exciting time for Jazz as we continue to transform to an
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |